康臣药业(01681)10月20日耗资约154.13万港元回购10万股
Core Viewpoint - 康臣药业 announced a share buyback plan, indicating a strategic move to enhance shareholder value by repurchasing 100,000 shares at a cost of approximately HKD 1.5413 million [1] Company Summary - 康臣药业 plans to repurchase 100,000 shares on October 20, 2025 [1] - The total expenditure for this buyback is around HKD 1.5413 million [1]